No Data
Citi Maintains ASTELLAS PHARMA(ALPMF.US) With Hold Rating, Cuts Target Price to $15.28
Pfizer, Astellas Win FDA Priority Review for Padcev in Bladder Cancer With Merck's Keytruda
ORIC Pharma Drops After Early-stage Trial Data for Prostate Cancer Therapy
ASTELLAS PHARMA To Go Ex-Dividend On March 30th, 2026 With 0.3432 USD Dividend Per Share
March 26th (Eastern Time) - $ASTELLAS PHARMA(ALPMF.US)$ is trading ex-dividend on March 30th, 2026.Shareholders of record on March 31st, 2026 will receive 0.3432 USD dividend per share on June 3rd, 20
Jefferies Upgrades ASTELLAS PHARMA(ALPMF.US) to Buy Rating, Raises Target Price to $17.56
Pfizer Posts Late-stage Trial Win for Talzenna Plus Xtandi in New Prostate Cancer Indication